Results
|
10161.
|
|
|
10162.
|
|
|
10163.
|
|
|
10164.
|
|
|
10165.
|
|
|
10166.
|
|
|
10167.
|
|
|
10168.
|
|
|
10169.
|
|
|
10170.
|
|
|
10171.
|
|
|
10172.
|
|
|
10173.
|
|
|
10174.
|
|
|
10175.
|
|
|
10176.
|
|
|
10177.
|
BCL2L10 is a predictive factor for resistance to azacitidine in MDS and AML patients. [electronic resource] by
- Cluzeau, Thomas
- Robert, Guillaume
- Mounier, Nicolas
- Karsenti, Jean Michel
- Dufies, Maeva
- Puissant, Alexandre
- Jacquel, Arnaud
- Renneville, Aline
- Preudhomme, Claude
- Cassuto, Jill-Patrice
- Raynaud, Sophie
- Luciano, Frederic
- Auberger, Patrick
Producer: 20121009
In:
Oncotarget vol. 3
Availability: No items available.
|
|
10178.
|
|
|
10179.
|
|
|
10180.
|
|